Is there a genetic factor in flecainide toxicity?
Beckmann
J
J
Abteilung für Experimentelle und Klinische Pharmakologie, Bundesgesundheitsamt, Berlin, Federal Republic of Germany.
Hertrampf
R
R
Gundert-Remy
U
U
Mikus
G
G
Gross
A S
AS
Eichelbaum
M
M
D005424:Flecainide / Q000009:adverse effects* / Q000378:metabolism / Q000493:pharmacokinetics; D006207:Half-Life; D006801:Humans; D008657:Metabolic Clearance Rate; D010641:Phenotype; D013034:Sparteine / Q000378:metabolism
D013034:Sparteine; D005424:Flecainide